1. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
- Author
-
N. Berthet, O. Faure, A. Bakri, P. Ambroise-Thomas, R. Grillot, and Brugère J.-F.
- Subjects
ASPERGILLUS nidulans ,PATHOLOGY ,ALBENDAZOLE - Abstract
The in vitro antifungal activity of albendazole, a benzimidazole widely used as an antihelmintic drug in humans, was investigated and assessed for its activity against Aspergillus spp. Forty-eight isolates, representing the most frequent species found in human pathology [Aspergillus fumigatus (n = 27), Aspergillus flavus (n = 10), Aspergillus terreus (n = 7), Aspergillus nidulans (n = 3) and Aspergillus niger (n = 1)], and one quality control strain (A. niger ATCC 9804 83435) were tested according to the NCCLS M38-P methodology for moulds. All the strains were susceptible to albendazole, with homogeneous MICs for each species; three strains were resistant to itraconazole. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF